Dysbiosis and Disease

Defining Dysbiosis - Gut Feeling Gone Wrong

Dysbiosis: Pathological imbalance in gut microbial community composition, function, or localization, disrupting host-microbe homeostasis (eubiosis) and host physiology.

• Key Features:
  • ↓ Microbial diversity (α-diversity)
  • Loss of beneficial microbes (e.g., Lactobacillus, Bifidobacterium, Faecalibacterium prausnitzii)
  • ↑ Pathobionts/opportunistic pathogens (e.g., Enterobacteriaceae, Clostridioides difficile)
  • Altered metabolic output (e.g., ↓ Short-Chain Fatty Acids like butyrate, ↑ harmful metabolites)
• 📌 Mnemonic "BAD Balance": Beneficials ↓, Altered diversity, Detrimental microbes ↑.

⭐ Dysbiosis is strongly linked to Inflammatory Bowel Disease (IBD), obesity, Type 2 Diabetes Mellitus, and an ↑ risk of C. difficile infection post-antibiotics.

Pathogenic Pathways - How Imbalance Hurts

• Metabolic Impact: ↓Butyrate (key SCFA) → impaired gut integrity, ↑inflammation. Altered bile acids.
• Immune Disturbance: Chronic inflammation (↑$TNF-\alpha$, $IL-6$). Skewed T-cell responses (↓Treg, ↑Th17).
• Barrier Breach: ↑Gut permeability → LPS translocation → endotoxemia.

  ⭐ LPS (endotoxin) translocation via leaky gut activates TLR4, fueling systemic inflammation; key in sepsis & metabolic disorders.

• Pathobiont Activity: ↑Toxins, LPS. Reduced colonization resistance allows pathogen overgrowth (e.g., C. difficile).

Dysbiosis & Disease - Flora's Foul Play

Dysbiosis: Microbial imbalance (composition/function). Results in ↓beneficial microbes (e.g., Lactobacillus, Bifidobacterium, F. prausnitzii), and/or ↑pathobionts.

Key Disease Associations:

• Gastrointestinal:
  • Inflammatory Bowel Disease (IBD) (Crohn's: ↓F. prausnitzii; Ulcerative Colitis)
  • Irritable Bowel Syndrome (IBS)
  • Clostridioides difficile Infection (CDI)
  • Colorectal Cancer (CRC) (e.g., Fusobacterium nucleatum)
• Metabolic:
  • Obesity (Altered Firmicutes/Bacteroidetes ratio)
  • Type 2 Diabetes (T2DM)
  • Non-alcoholic Fatty Liver Disease (NAFLD)
• Immune/Autoimmune:
  • Allergies, Asthma
  • Rheumatoid Arthritis, Multiple Sclerosis (MS)
• Neuropsychiatric (Gut-Brain Axis):
  • Anxiety, Depression, Autism Spectrum Disorder (ASD)

Core Mechanisms:

• ↑Intestinal permeability ("leaky gut")
• Altered metabolites: ↓Short-Chain Fatty Acids (SCFAs like butyrate $C_4H_8O_2$), ↑Lipopolysaccharide (LPS), ↑Trimethylamine N-oxide (TMAO)
• Chronic inflammation, Immune dysregulation

⭐ Fecal Microbiota Transplantation (FMT) demonstrates >90% efficacy for recurrent C. difficile infection (rCDI), a key therapeutic intervention to restore eubiosis.

Diagnosis & Correction - Fixing the Flora

• Diagnosis:
  • Clinical context crucial.
  • Stool analysis: 16S rRNA gene sequencing (identifies bacteria), metagenomics (functional potential, other microbes).
  • Breath tests: Hydrogen/methane for Small Intestinal Bacterial Overgrowth (SIBO).
  • Biomarkers: Fecal calprotectin (gut inflammation, e.g., IBD).
• Correction Strategies:
  • Dietary Modulation: Foundation.
    • Prebiotics (e.g., inulin, FOS, GOS) - fuel beneficial microbes.
    • Probiotics (e.g., Lactobacillus spp., Bifidobacterium spp.) - introduce beneficial microbes.
    • Synbiotics (Pre + Pro).
  • Fecal Microbiota Transplantation (FMT):

    ⭐ FMT shows >90% efficacy for recurrent Clostridioides difficile infection (CDI).

    • Donor screening critical. Investigational for IBD, IBS, autism.
  • Antibiotics: Targeted & judicious (e.g., Rifaximin for SIBO, Vancomycin for CDI).
  • Emerging: Phage therapy, engineered probiotics, postbiotics.

High‑Yield Points - ⚡ Biggest Takeaways

• Dysbiosis: Critical imbalance in gut microbiota composition/function, predisposing to disease.
• Linked to IBD (Crohn's, UC), IBS, obesity, Type 2 Diabetes, and allergic disorders.
• Clostridioides difficile infection (CDI): Classic severe dysbiosis, often post-antibiotics.
• Fecal Microbiota Transplantation (FMT): Highly effective for recurrent CDI, restores balance.
• Mechanisms: Altered metabolites (↓SCFAs), immune dysregulation, impaired gut barrier integrity.
• Antibiotic overuse is a major driver; probiotics/prebiotics aim to restore eubiosis.